Weekly News Recap #Phispers
Lilly to invest US$ 3 bn in China to boost supply of new obesity drug; Servier acquires Day One Biopharma for US$ 2.5 bn

Lilly to invest US$ 3 bn in China to boost supply of new obesity drug; Servier acquires Day One Biopharma for US$ 2.5 bn

In Phispers this week, Eli Lilly announced its plans to invest US$ 3 billion in China over the next decade in order to build p...

Impressions : 2553

Trump withdraws US from WHO; Novo’s Ozempic, Wegovy among 15 new drugs chosen for price negotiations under IRA

Trump withdraws US from WHO; Novo’s Ozempic, Wegovy among 15 new drugs chosen for price negotiations under IRA

On the day Donald Trump was sworn in as the 47th President of the United States, there was a deluge of some 200 measures, which...

Impressions : 1889

Lilly to acquire IBD drug developer Morphic for US$ 3.2 bn; Pfizer’s R&D chief to step down

Lilly to acquire IBD drug developer Morphic for US$ 3.2 bn; Pfizer’s R&D chief to step down

This week saw Eli Lilly strike yet another deal as it announced the acquisition of Morphic Holding for about US$ 3.2 billion, t...

Impressions : 1364

2020 begins with drug price increases in US and mysterious illness in China

This week in Phispers, we have news about pharmaceutical companies ushering in the new year with a hike in US list prices of ov...

Impressions : 2771